Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun;28(3):e70273.
doi: 10.1111/hex.70273.

Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023

Affiliations

Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023

Essa Tawfiq et al. Health Expect. 2025 Jun.

Abstract

Background: Limited data exists regarding long Covid burden following Omicron infection in highly vaccinated populations.

Objective: To (1) characterise long Covid prevalence and predictors and (2) identify key symptom clusters and their correlates among long Covid patients, during an Omicron-predominant period in a highly vaccinated population.

Design: Anonymous, online, cross-sectional survey.

Setting: January 2023, Australia.

Participants: Residents aged ≥ 18 years with self-reported history of test-positive Covid-19. The main variables studied were socio-demographic characteristics, Covid-19 risk factors, vaccination, infection history and experiences with long Covid.

Main outcome measures: Long Covid symptoms. Symptom-based clustering was used to identify long Covid symptom clusters and their functional correlates. Predictors of long Covid occurrence and severity were assessed using multivariable logistic regression.

Results: Overall, 240/1205 participants (19.9%) reported long Covid. Long Covid risk was significantly higher for women OR 1.71 (95% CI: 1.17-2.51), people with comorbidities 2.19 (95% CI: 1.56-3.08) and those using steroid inhalers for Covid-19 treatment (2.34 [95% CI: 1.29-4.24]). Long-Covid risk increased with increasing Covid-19 infection severity (moderately severe symptoms: 2.23 [95% CI: 1.50-3.30], extremely severe symptoms: 5.80 [95% CI: 3.48-9.66], presented to ED/hospitalised: 7.22 [95% CI: 3.06-17.03]). We found no significant difference in the likelihood of long Covid between the Omicron and pre-Omicron periods, vaccination status and participant age. We identified two long Covid clusters (pauci-symptomatic, n = 170, vs. polysymptomatic, n = 66). Polysymptomatic cluster membership was associated with worse functioning (impacts on work, moderate activity, emotions and energy). Severity acute infection was strongly predictive of polysymptomatic cluster membership (5.72 [2.04-17.58]). Monoclonal antibody treatment was strongly associated with pauci-symptomatic cluster membership (0.02 [0.00-0.13]).

Discussion: Our study shows that long Covid is an important health burden in Australia, including during the Omicron era, and identifies several risk factors. We found a subgroup of patients characterised by more symptoms and worse functional outcomes. Our findings can inform policies for protecting vulnerable populations and frameworks for long Covid risk assessment and management.

Conclusions: One-in-five people may suffer long Covid after acute Covid-19 infection, with similar risk across age groups. Omicron variants appear not to have a lower risk compared to earlier variants in our study. A cumulative number of symptoms can help triage long Covid patients.

Patient or public contribution: We did not involve patients or the public in the design of the questionnaire. However, after a soft launch, we revised some survey questions by reviewing early responses from patients and the public.

Keywords: Australia; Covid‐19; Omicron; SARS‐CoV‐2; long Covid.

PubMed Disclaimer

Conflict of interest statement

E.T., R.C., D.A.H., R.D., M.K., A.N., H.S. and D.A. authors declare no conflicts of interest. D.G. is a member of OzSAGE. C.R.M. is on the WHO COVID‐19 Vaccine Composition Technical Advisory Group and the WHO SAGE Working Group on Smallpox and Monkeypox. She receives funding from Sanofi for influenza and pertussis research and from NHMRC and MRFF.

Figures

Figure 1
Figure 1
Study population and inclusion and exclusion criteria.
Figure 2
Figure 2
Predictors of long Covid—multivariable regression model (Model 2).
Figure 3
Figure 3
Characteristics of long Covid participants belonging to the pauci‐symptomatic and polysymptomatic clusters at the time of survey. Kruskal–Wallis test was applied to non‐normally distributed continuous variables and ordinal variables. Pearson's χ 2 was applied to categorical predictor variables. Categories with cell counts less than 5 were excluded from analysis, which included ‘Gender: Non‐binary’. For a detailed frequency table, see Table S13. *p value < 0.05, **p value < 0.001.
Figure 4
Figure 4
Forest plot showing adjusted odds ratios and 95% confidence interval for predictors of polysymptomatic cluster membership (PAM method). Blue squares indicate the odds ratio, and horizontal lines depict the 95% confidence interval.
Figure 5
Figure 5
(A–D) Functional correlates and post‐COVID outcomes of long COVID participants belonging to the pauci‐symptomatic and polysymptomatic clusters. Kruskal–Wallis test was applied to non‐normally distributed continuous variables and ordinal variables. Pearson's χ 2 was applied to categorical predictor variables. Categories with cell counts less than 5 were excluded from analysis, which included ‘Change in health self‐rating post‐COVID: Improved’. For a detailed frequency table, see Table S14. *p value < 0.05, **p value < 0.001.

Similar articles

References

    1. Chang S. L., Nguyen Q. D., Martiniuk A., Sintchenko V., Sorrell T. C., and Prokopenko M., “Persistence of the Omicron Variant of SARS‐CoV‐2 in Australia: The Impact of Fluctuating Social Distancing. PLOS Glob,” PLOS Global Public Health 3, no. 4 (2023): e0001427. - PMC - PubMed
    1. World Health Organization . “A Clinical Case Definition of Post COVID‐19 Condition by a Delphi Consensus,” retrieved November 6, 2022, https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_cond....
    1. Munblit D., Nicholson T. R., Needham D. M., et al., “Studying the Post‐COVID‐19 Condition: Research Challenges, Strategies, and Importance of Core Outcome Set Development,” BMC Medicine 20, no. 1 (2022): 50. - PMC - PubMed
    1. Chen C., Haupert S. R., Zimmermann L., Shi X., Fritsche L. G., and Mukherjee B., “Global Prevalence of Post‐Coronavirus Disease 2019 (COVID‐19) Condition or Long Covid: A Meta‐Analysis and Systematic Review,” Journal of Infectious Diseases 226, no. 9 (2022): 1593–1607. - PMC - PubMed
    1. Adjaye‐Gbewonyo A., Vahratian A., Perrine C. G., and Bertolli J., “Long COVID in Adults: United States, 2022,” NCHS Data Brief, no 480 (National Center for Health Statistics, 2023), 10.15620/cdc:132417. - DOI - PubMed

Substances

LinkOut - more resources